The Company holds a 51% interest in CMTG/TT as a result of committing to invest $124.9 million in CMTG/TT. Distributions representing repayment proceeds from CMTG/TT’s loans may be recalled by CMTG/TT at a price of $10.00 per Common Unit, if the repayment occurred at least six months prior to the loan’s initial maturity date. As of December 31, 2021 and 2020, the Company had contributed $162.1 million and $159.5 million, respectively to CMTG/TT and has received return of capital distributions of $123.2 million, of which $111.1 million were recallable. As of December 31, 2021 and 2020, CMTG’s remaining capital commitment to CMTG/TT was $73.8 million and $76.4 million, respectively.

The Company had a capital commitment of $1.1 million to CMTG TT Participation Investor, LP (“CMTG TT Participation”), a Delaware limited partnership formed for the purpose of participating in future investments made by the Company for which the projected equity required exceeds $100.0 million. The general partner of CMTG TT Participation is CMTG TT Participation Investor GP, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company. CMTG TT Participation never commenced operations. In November 2021, upon the completion of the Company’s initial public offering, the Company’s unfunded commitment to CMTG TT Participation was cancelled.

As of December 31, 2021 and 2020, the Company had unfunded loan commitments of $1.1 billion and $1.4 billion relating to 49 and 52 loans receivable and interests in loans receivable, respectively, which amounts will generally be funded to finance lease-related or capital expenditures by the Company’s borrowers, subject to borrowers achieving certain conditions precedent to such funding. These future commitments will expire over the remaining term of the loans, none of which exceed five years.

As of December 31, 2021 and 2020, the Company had $584.3 million and $650.9 million, of approved but undrawn capacity on existing secured financing commitments, which may be drawn subject to certain conditions.

The Company’s contractual payments due under all borrowings by maturity were as follows as of December 31, 2021 (in thousands):

Year	Amount
2022		1,493,693
2023		393,895
2024		1,763,800
2025		374,954
2026		732,208
Thereafter		—
	$	4,758,550

The Company had provided a contingent guaranty relating to a note payable financing which requires the Company to fund equity sufficient to complete the borrower’s business plan in the event that the borrower defaults on its loan obligations. The note payable was repaid on May 27, 2021 and the contingent equity funding guaranty was terminated. At December 31, 2020, the estimated equity required to complete the borrower’s business plan was $2.6 million.

On two separate occasions, the Company entered into arrangements with borrowers whereby the Company may advance additional funds on existing loans in excess of the primary mortgage and mezzanine loan commitment amounts, at interest rates which exceed the rate stated in the underlying mortgage or mezzanine loan. As of December 31, 2021 and 2020, the Company had a commitment of $0 and $55.0 million resulting from such arrangements, respectively, and during the year ended December 31, 2021 both arrangements were terminated. No amounts were drawn under these arrangements.

In the normal course of business, the Company may enter into contracts that contain a variety of representations and provide for general indemnifications. The Company’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, based on experience, the Company expects the risk of loss to be remote.

The full impact of COVID-19 on the global economy and the Company’s business is uncertain. As of December 31, 2021, no contingencies have been recorded on the Company’s consolidated balance sheets as a result of COVID-19, however as the global pandemic continues and the economic implications become better known, it may have long-term impacts on the Company’s financial condition, results of operations, and cash flows. Refer to Note 2 for further discussion of COVID-19.